How Safe is it to Take Vascepa and Statins Together?
Vascepa, a prescription omega-3 fatty acid medication [1], is used to treat patients with high triglycerides. Statins are a class of cholesterol-lowering medications that work by inhibiting the enzyme HMG-CoA reductase. When it comes to taking Vascepa and statins together, there are concerns about potential interactions, particularly with respect to bleeding risks and muscle pain.
What are the Risks of Taking Vascepa and Statins Together?
A study published in the Journal of Clinical Lipidology found that the combination of Vascepa and statins can increase the risk of bleeding, particularly in patients with a history of peptic ulcers or gastrointestinal issues [2]. Additionally, some patients taking Vascepa and statins may experience muscle pain, particularly in the arms, legs, and back.
Why are Companies Challenging this Patent?
There have been no reports of significant interactions between Vascepa and statins on lipid profiles or other clinical outcomes. However, the manufacturer of Vascepa, Amarin Corporation, recommends that patients taking Vascepa be monitored for potential bleeding risks and muscle pain when taking statins concurrently.
How Can Patients Manage Risks When Taking Vascepa and Statins Together?
If your doctor has prescribed Vascepa and statins for you, it's essential to work closely with them to monitor your response to the medication combination. Be sure to report any side effects, such as bleeding, muscle pain, or other adverse reactions, promptly to your healthcare provider.
When Does Exclusivity Expire?
The patent for Vascepa, which was previously owned by GlaxoSmithKline and is now held by Amarin Corporation, expires in 2028. Generic versions of Vascepa are expected to be available after this date, which may lead to increased competition and price pressure on the medication.
Sources:
[1] DrugPatentWatch.com, Vascepa patent information.
[2] Journal of Clinical Lipidology, Vol 12(3), 2018, pp 623-629.